The US Preventive Services Task Force (USPSTF) published its strongest recommendation that clinicians should prescribe pre-exposure prophylaxis (PrEP) with effective antiretroviral therapy to people at increased risk of HIV acquisition.
The recommendations in JAMA on Tuesday came as part of an update to a 2019 review, and USPSTF gave its…
Click here to view original post
